AMICUS THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.28 USD | +1.08% |
|
-3.11% | -27.55% |
Chart calendar Amicus Therapeutics, Inc.
1adfb153fece875a4516.U5HuEbQv3xUlQNq__hmShbUiham7ga8frZ85jx8qa1A.J_eDKMRup3FWBLn4s1H07-pszOT12fZd1Olz91UaWGYR5NdUjGKbemsh4g~45fd546ea5b8a221565092e99a3f484e
Upcoming events on Amicus Therapeutics, Inc.
Past events on Amicus Therapeutics, Inc.
| 12/03/2024 12:50 am | Leerink Partners Global Biopharma Conference |
| 04/03/2024 09:40 pm | TD Cowen Health Care Conference |
| 28/02/2024 07:00 pm | Q4 2023 Earnings Call |
| 28/02/2024 05:30 pm | Q4 2023 Earnings Release |
| 09/02/2024 04:30 am | WORLD Symposium - Poster No:241 |
| 09/02/2024 04:30 am | WORLD Symposium - Poster No:346 |
| 09/02/2024 04:30 am | WORLD Symposium - Poster No:165 |
| 08/02/2024 10:42 pm | WORLD Symposium |
| 08/02/2024 04:30 am | WORLD Symposium - Poster No:339 |
| 08/02/2024 04:30 am | WORLD Symposium - Poster No:8 |
| 08/02/2024 04:30 am | WORLD Symposium - Poster No:293 |
| 08/02/2024 04:30 am | WORLD Symposium - Poster No:189 |
| 08/02/2024 04:30 am | WORLD Symposium - Poster No:320 |
| 08/02/2024 04:30 am | WORLD Symposium - Poster No:232 |
| 08/02/2024 04:30 am | WORLD Symposium - Poster No:279 |
| 08/02/2024 04:30 am | WORLD Symposium - Poster No:262 |
| 08/02/2024 04:30 am | WORLD Symposium - Poster No:246 |
| 09/01/2024 03:45 am | JPMorgan Healthcare Conference |
| 15/11/2023 06:30 pm | Stifel Healthcare Conference |
| 09/11/2023 11:30 pm | UBS BioPharma Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 182 180 1.31% | 261 260 0.52% | 306 307 -0.39% | 329 329 0.1% | 399 399 0% | 529 |
|
EBITDA Million USD | Released Forecast Spread | -299 -280 -6.79% | -238 -229 -4.08% | -200 -169 -18.19% | -207 -183 -13.17% | -69,3 -67,8 -2.22% | 47,5 |
|
EBIT Million USD | Released Forecast Spread | -304 -276 -10.22% | -247 -236 -4.66% | -206 -172 -19.97% | -212 -195 -8.52% | -77,2 -79,4 2.74% | 40,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -356 -328 -8.42% | -274 -252 -8.95% | -242 -199 -21.26% | -242 -216 -12.2% | -150 -133 -12.49% | -3,01 |
|
Net income Million USD | Released Forecast Spread | -356 -329 -8.36% | -277 -256 -8.34% | -250 -205 -21.99% | -237 -223 -6.06% | -152 -133 -14.32% | -1,48 |
|
EPS USD | Released Forecast Spread | -1,48 -1,38 -7.21% | -1,07 -0,99 -7.89% | -0,92 -0,76 -20.7% | -0,82 -0,77 -5.87% | -0,51 -0,45 -13.36% | -0,01 |
| Announcement Date | 02/03/20 | 01/03/21 | 24/02/22 | 01/03/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 82,2 83,5 -1.67% | 78,7 77,1 2.04% | 80,7 85,9 -6% | 81,7 84,2 -2.98% | 88,1 87,8 0.38% | 86,3 83,2 3.68% | 94,5 89,9 5.16% | 104 101 2.1% | 115 115 0.03% | 111 | 125 | 139 | 156 | 145 |
|
EBITDA Million USD | Released Forecast Spread | -70,6 -29,6 -138.94% | -67,3 -51,8 -29.94% | -59,3 -48,5 -22.28% | -32,6 -37,2 12.6% | -41,0 1,58 -2701.94% | -36,4 -30,5 -19.25% | -16,7 -22,9 27.42% | -14,8 -10,0 -47.28% | -1,51 -19,9 92.43% | -14,4 | -3,70 | 7,42 | 26,0 | |
|
EBIT Million USD | Released Forecast Spread | -72,1 -38,0 -89.78% | -75,3 -67,5 -11.65% | -60,6 -54,7 -10.89% | -33,8 -50,8 33.42% | -42,3 -35,2 -20.35% | -37,6 -36,0 -4.63% | -18,9 -23,3 19.14% | -17,0 -9,86 -72.61% | -3,69 -5,70 35.23% | -8,68 | 4,21 | 15,7 | 28,9 | 15,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -80,3 -43,7 -83.6% | -81,5 -74,8 -8.95% | -61,2 -62,5 1.97% | -29,3 -58,1 49.62% | -70,1 -41,1 -70.55% | -53,2 -44,3 -20.12% | -40,5 -32,4 -24.96% | -24,7 -21,6 -14.23% | -31,7 -15,4 -105.44% | -18,5 | -6,06 | 9,09 | 21,9 | 4,71 |
|
Net income Million USD | Released Forecast Spread | -83,3 -42,7 -95.12% | -85,3 -71,6 -19.11% | -62,2 -62,5 0.52% | -33,3 -58,1 42.73% | -55,9 -37,3 -49.86% | -52,9 -41,0 -28.99% | -43,2 -33,2 -30.07% | -21,6 -21,6 0.19% | -33,8 -17,0 -99.21% | -19,7 | -7,39 | 7,04 | 20,6 | 4,71 |
|
EPS USD | Released Forecast Spread | -0,29 -0,16 -85.49% | -0,30 -0,26 -16.02% | -0,21 -0,22 3.21% | -0,12 -0,20 39.26% | -0,19 -0,13 -43.24% | -0,18 -0,15 -20.88% | -0,15 -0,11 -31.94% | -0,07 -0,08 7.2% | -0,11 -0,06 -87.43% | -0,06 | -0,02 | 0,02 | 0,06 | 0,01 |
| Announcement Date | 24/02/22 | 09/05/22 | 04/08/22 | 07/11/22 | 01/03/23 | 10/05/23 | 08/08/23 | 08/11/23 | 28/02/24 | - | - | - | - | - |
More events
Past sector events for Amicus Therapeutics, Inc.
| Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FOLD Stock
- Calendar Amicus Therapeutics, Inc.
